About this episode
The future of healthcare and machine intelligence, featuring Dr Phillip Alvelda, the founder and chairman of Medio Labs. The pandemic accelerated the introduction of direct-to-consumer healthcare with clinical grade accuracy. Phillip explains how AI will amplify this process by reducing cost to scale. But the prospect of constant surveillance raises other concerns, and that leads to a lively Futurists debate about China’s advances in AI and a new round of US export controls.
Get every episode summarized
Each time The Futurists publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
